FDA recall D-0023-2026

STAQ Pharma, Inc. · Class III · drug

Product

Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Distribution

Nationwide in the U.S.

Key facts

Status: Ongoing
Initiation date: 2025-10-09
Report date: 2025-10-22
Voluntary/Mandated: Voluntary: Firm initiated
Location: Denver, CO, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0023-2026